Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ghassan Boghosian

Adult Reconstructive Orthopaedic Surgery Rancho Mirage, CA Doctor of Osteopathy

NPI 1255479044 CMS profile 283690

39000 Bob Hope Dr, Harry And Diane Rinker Blg, Rancho Mirage, CA 92270

Open in the dashboard

General payments

$558,025

551 records reported · program years 2019–2025

Research payments

$2,750

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$137,499 paid to institutions, not to them · program years 2020–2024

Through program year 2025, Ghassan Boghosian of Rancho Mirage, CA is reported in the CMS Open Payments database as having received $558,025 across 551 general payments and $2,750 in research payments paid to them. Separately, studies naming them as principal investigator received $137,499 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $80,235 81
2024 General $75,791 67
2023 General $41,981 67
2022 General $128,792 123
2021 General $99,668 90
2020 General $60,729 48
2019 General $70,829 75
2019 Research $2,750 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ghassan Boghosian
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Ghassan Boghosian were reported at $80,235. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Ghassan Boghosian Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $70,829 $1,416 $292–$9,336 $163
2020 $60,729 $647 $141–$6,474 $114
2021 $99,668 $1,073 $211–$6,497 $132
2022 $128,792 $1,217 $236–$6,299 $149
2023 $41,981 $1,082 $246–$6,818 $160
2024 $75,791 $1,575 $323–$8,944 $164
2025 $80,235 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $407,293 376 payments
  2. TechMah Medical, LLC $78,187 61 payments
  3. Ortho Development Corporation $29,773 14 payments
  4. Advanced Orthopaedic Solutions, Inc. $23,500 8 payments
  5. Arthrex, Inc. $8,922 5 payments
  6. Conformis, Inc. $3,433 13 payments
  7. Lima USA, Inc. $2,928 9 payments
  8. Encore Medical, LP $739 5 payments
  9. Ferring Pharmaceuticals Inc. $537 21 payments
  10. NextStep Arthropedix, LLC $481 2 payments
  11. Other $2,232 37 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $440,350 123 payments
  2. Travel and Lodging $53,518 165 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $42,200 14 payments
  4. Food and Beverage $21,877 248 payments
  5. Education $80 1 payment
Products named General payments · program years 2019–2025
  1. MAKO Knees, Hips $363,859 297 payments
  2. SmartSpace Hip $29,411 16 payments
  3. SmartSpace Knee $25,857 22 payments
  4. BKS TriMax $24,333 8 payments
  5. MAKO Knees, Hips $23,066 34 payments
  6. Smart SPACE $22,918 23 payments
  7. TRIATHLON $17,809 13 payments
  8. AOS PRODUCTS $14,100 4 payments
  9. TRITANIUM $13,084 11 payments
  10. Trochanteric Nail $9,400 4 payments
  11. Other $40,291 144 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Limacorporate S.p.A. $2,750 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

325

Median for Orthopedic Surgery: 203

Drug cost

$4,015

Median for Orthopedic Surgery: $1,433

Branded share of claims

37.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 72 $1,816
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 71 $780
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 52 $649
Doxycycline Hyclate Generic 45 $399
Tramadol Hcl Generic 24 $117
Cephalexin Generic 12 $106
Meloxicam Generic 20 $64
Gabapentin Generic 11 $47
Amoxicillin Generic 18 $35

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$707,145

Medicare's payments for the services billed

Medicare patients

1,041

Average age 76

Services billed

2,881

609 women, 432 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Ischemic heart disease 31%
Depression 26%
Chronic kidney disease 23%
Osteoporosis 23%
Diabetes 22%
Atrial fibrillation 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

553 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record